James Roth Sells 2,000 Shares of Huron Consulting Group (NASDAQ:HURN) Stock

Huron Consulting Group Inc. (NASDAQ:HURN) Director James Roth sold 2,000 shares of Huron Consulting Group stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $146.30, for a total transaction of $292,600.00. Following the sale, the director owned 39,304 shares in the company, valued at approximately $5,750,175.20. This represents a 4.84% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Huron Consulting Group Price Performance

Shares of NASDAQ HURN opened at $150.32 on Friday. Huron Consulting Group Inc. has a fifty-two week low of $102.94 and a fifty-two week high of $155.00. The firm’s 50-day simple moving average is $137.87 and its 200 day simple moving average is $139.67. The company has a quick ratio of 1.99, a current ratio of 1.99 and a debt-to-equity ratio of 1.35. The stock has a market cap of $2.60 billion, a P/E ratio of 26.23 and a beta of 0.29.

Huron Consulting Group (NASDAQ:HURN) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.79 by $0.10. Huron Consulting Group had a net margin of 6.60% and a return on equity of 25.52%. The business had revenue of $402.50 million for the quarter, compared to analysts’ expectations of $402.67 million. During the same period in the previous year, the business earned $1.68 earnings per share. The company’s revenue was up 8.3% on a year-over-year basis. Huron Consulting Group has set its FY 2025 guidance at 7.300-7.70 EPS. Equities analysts expect that Huron Consulting Group Inc. will post 6.1 EPS for the current year.

Analysts Set New Price Targets

HURN has been the topic of several research reports. Weiss Ratings reiterated a “buy (b)” rating on shares of Huron Consulting Group in a research report on Saturday, September 27th. Wall Street Zen cut shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a research report on Saturday, August 9th. Finally, Barrington Research boosted their price target on shares of Huron Consulting Group from $173.00 to $176.00 and gave the stock an “outperform” rating in a research report on Thursday, August 7th. Six research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $171.50.

Institutional Investors Weigh In On Huron Consulting Group

Large investors have recently made changes to their positions in the company. Quarry LP bought a new stake in shares of Huron Consulting Group in the 1st quarter valued at approximately $31,000. Opal Wealth Advisors LLC bought a new stake in shares of Huron Consulting Group in the 1st quarter valued at approximately $35,000. N.E.W. Advisory Services LLC bought a new stake in shares of Huron Consulting Group in the 2nd quarter valued at approximately $41,000. EverSource Wealth Advisors LLC grew its stake in shares of Huron Consulting Group by 1,018.2% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 369 shares of the business services provider’s stock valued at $51,000 after buying an additional 336 shares in the last quarter. Finally, CWM LLC grew its stake in shares of Huron Consulting Group by 55.9% in the 1st quarter. CWM LLC now owns 407 shares of the business services provider’s stock valued at $58,000 after buying an additional 146 shares in the last quarter. Institutional investors own 93.90% of the company’s stock.

Huron Consulting Group Company Profile

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.